论文部分内容阅读
目的:探讨针对特发性间质性肺炎(IIP)患者,选择糖皮质激素(常规剂量)完成治疗后的临床效果表现。方法:选取我院2013年11月—2014年07月IIP患者72例。对患者临床呼吸困难程度、患者常规胸片检查结果、患者血气分析结果以及患者运动肺功能进行观察,对患者实施CRP(临床-影像-生理)评分,对患者选择强的松(0.5 mg·kg-1·d-1)进行为期一个月的治疗,之后针对CRP评分结果进行复查。结果:对患者选择强的松给予临床治疗,同准备治疗前进行比较,患者CRP评分表现为显著下降,对患者进行配对t检验,最终发现患者CRP评分下降表现出统计学意义(P<0.05)。结论:通过CRP评分系统对患者的临床疗效指标进行分析,最终发现,针对间质性肺炎患者,选择糖皮质激素给予临床治疗,临床可以获得显著疗效。
Objective: To investigate the clinical effect of selective glucocorticoid (conventional dose) on patients with idiopathic interstitial pneumonia (IIP). Methods: 72 patients with IIP in our hospital from November 2013 to July 2014 were selected. The degree of clinical dyspnea, the results of routine chest radiography, blood gas analysis results and lung function of patients were observed. CRP (clinical-imaging-physiology) was scored on patients and prednisone (0.5 mg · kg -1 -1 · d-1) for a month of treatment, followed by review of CRP score results. Results: Compared with pre-treatment, CRP scores of patients were significantly decreased after treatment with prednisone. Paired t-test was performed on patients with CRP. The CRP score of patients showed a significant decrease (P <0.05) . Conclusion: Through clinical analysis of CRP score system, we found that for the patients with interstitial pneumonia, glucocorticoid was given to clinical treatment and clinical effect could be obtained clinically.